<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Kent_Description skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Kent/Description</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="navbox"><NAV id="navdiv"><UL><LI><A href="#">Project</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Description">Description</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Model">Modelling</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Results">Results</A></LI></UL><LI><A href="#">Parts</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Basic_Part">Basic Parts</A></LI><LI><A href="#">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Notebook">Logbook</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Experiments">Experiments</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Improve">Future Ideas</A></LI><LI><A href="#">Safety</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Safety">Project Safety</A></LI><LI><A href="#">Team</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Team">Meet the Team</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Contribution">Contribution</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Attributions">Attribution</A></LI><LI><A href="#">Human Practices</A></LI><LI><A href="https://2017.igem.org/Team:Kent/HP/Silver">Integrated HP</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Engagement">Public Engagement</A></LI><LI><A href="https://2017.igem.org/Team:Kent/InterLab">Interlab</A></LI><LI><A href="https://2017.igem.org/Team:Kent/Collaborations">Collaboration</A></LI></NAV></DIV><DIV id="title"><SPAN>Description </SPAN></DIV><DIV id="box1"><DIV class="centerizer"><SPAN>iGEM Project Discription</SPAN></DIV><DIV id="textbox1"><P>A multitude of genetically inherited and acquired diseases can be traced back to faulty or altered mRNA
expression in eukaryotic cells. (1) To be able to treat these diseases and develop efficient therapeutic
agents, the exact molecular mechanisms underlying faulty mRNA synthesis and export must be
elucidated. Furthermore, studies of healthy cell proliferation and differentiation also indicate a degree
of subcellular localization, which yet has to be investigated further to be explained and understood.(2)
Our CRISPR/dCas13a construct functions as an “mRNA localization device” to investigate the fate of
mRNA in vivo.
</P></DIV><DIV class="centerizer"><SPAN>dCAS13a</SPAN><DIV id="textbox2"><P>Cas13a is a RNA guided endonuclease which degrades RNAs based on alignment of its CRISPR derived
crRNA. We used dead Cas13a with four mutations, two in HEPN1 and two in the HEPN2 domains, which
abort its nuclease activity, but maintain its helicase properties, resulting instead in attachment of
dCAS13a to the targeted RNA sequence.
</P></DIV><DIV class="centerizer"><SPAN>gRNAs</SPAN><DIV id="textbox3"><P>Simultaneously, guide RNAs constructs (for crRNA expression) destined for incorporation into the
bacterial genome within CRISP repeats was designed. These constructs contain a U6 promoter followed
by coding sequences for human β-Actin, pkp4, inpp-1, and Rab13 (individually) and terminated by an
oligo (T) repeat. The protein sequences are chosen based on susceptibility to mutations and expression
in disease states.
</P></DIV><DIV class="centerizer"><SPAN>Lucas</SPAN><DIV id="textbox4"><P>With the aim to investigate and track mRNA localization in vivo, we engineered a gene construct
containing a GFP attached via a linker sequence, allowing conformational flexibility, to a dCas13a coding
gene. Additionally, two Nuclear localization sequences are on either side of the construct, which
navigate the fusion protein back to the cell nucleus after protein synthesis in the ER is completed. In the
nucleus, the protein construct recognizes the CRISPR incorporated sequence and attaches to it. When
the targeted mRNA is consequently exported, the GFP+dCas13a tags along, allowing the ‘tracking’ of
mRNA up until its translation in the ER. The unbound fusion protein constructs are retained in the
nucleus and do not localize within the cell cytoplasm, reducing background noise.
</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>